Peyronie病的临床诊治研究(5)
[18]Bekos A，Arvaniti M，Hatzimouratidis K，et al.The natural history of Peyronie's disease：an ultrasonography-based study[J].European Urology，2008，53(3)：644-650.
[19]Levine LA，Greenfield JM.Establishing a standardized evaluation of the man with Peyronie's disease[J].International Journal of Impotence Research，2003，15(Suppl 5)：S103-S112.
[20]Jung DC，Park SY，Lee JY.Penile Doppler ultrasonography revisited[J].Ultrasonography，2018，37(1)：16-24.
, http://www.100md.com
[21]Hauck EW，Hackstein N，Vosshenrich R，et al.Diagnostic value of magnetic resonance imaging in Peyronie's disease--a comparison both with palpation and ultrasound in the evaluation of plaque formation[J].European Urology，2003，43(3)：293-299.
[22]Nehra A，Alterowitz R，Culkin DJ，et al.Peyronie's Disease：AUA Guideline[J].The Journal of Urology，2015，194(3)：745-753.
[23]Kayes O，Khadr R.Recent advances in managing Peyronie's disease[J].F1000Research，2016，5(F1000 Faculty Rev)：2372.
, 百拇医药
[24]Russo GI，Milenkovic U，Hellstrom W，et al.Clinical Efficacy of Injection and Mechanical Therapy for Peyronie's Disease：A Systematic Review of the Literature[J]. European Urology，2018，74(6)：767-781.
[25]Sokhal AK，Jain NK，Jhanwar A，et al.Prospective study to evaluate the clinical outcome of intralesional interferon-α2b in the management of Peyronie's disease[J]. Urology Annals，2018，10(2)：154-158.
[26]Ziegelmann MJ，Viers BR，Montgomery BD，et al.Self-reported Clinical Meaningfulness Early in the Treatment Course Predicts Objective Outcomes in Men Undergoing Collagenase Clostridium histolyticum Injections for Peyronie Disease[J].Urology，2017(106)：107-112.
, http://www.100md.com
[27]Hellstrom WJG，Tan RBW，Liu G.Safety Profile of Collagenase Clostridium Histolyticum Stratified by Degree of Penile Curvature in Patients With Peyronie Disease[J].Urology，2017， 106(237)：e9-e14.
[28]Abdel Raheem A，Capece M，Kalejaiye O，et al.Safety and effectiveness of collagenase clostridium histolyticum in the treatment of Peyronie's disease using a new modified shortened protocol[J].BJU International，2017，120(5)：717-723.
[29]Carson CC，Sadeghi-Nejad H，Tursi JP，et al.Analysis of the clinical safety of intralesional injection of collagenase Clostridium histolyticum (CCH) for adults with Peyronie's disease(PD)[J].BJU International，2015，116(5)：815-822.
[30]Martínez-Salamanca JI，Egui A，Moncada I，et al.Acute phase Peyronie's disease management with traction device：a nonrandomized prospective controlled trial with ultrasound correlation[J].The Journal of Sexual Medicine，2014，11(2)：506-515., 百拇医药(丁黎)
[19]Levine LA，Greenfield JM.Establishing a standardized evaluation of the man with Peyronie's disease[J].International Journal of Impotence Research，2003，15(Suppl 5)：S103-S112.
[20]Jung DC，Park SY，Lee JY.Penile Doppler ultrasonography revisited[J].Ultrasonography，2018，37(1)：16-24.
, http://www.100md.com
[21]Hauck EW，Hackstein N，Vosshenrich R，et al.Diagnostic value of magnetic resonance imaging in Peyronie's disease--a comparison both with palpation and ultrasound in the evaluation of plaque formation[J].European Urology，2003，43(3)：293-299.
[22]Nehra A，Alterowitz R，Culkin DJ，et al.Peyronie's Disease：AUA Guideline[J].The Journal of Urology，2015，194(3)：745-753.
[23]Kayes O，Khadr R.Recent advances in managing Peyronie's disease[J].F1000Research，2016，5(F1000 Faculty Rev)：2372.
, 百拇医药
[24]Russo GI，Milenkovic U，Hellstrom W，et al.Clinical Efficacy of Injection and Mechanical Therapy for Peyronie's Disease：A Systematic Review of the Literature[J]. European Urology，2018，74(6)：767-781.
[25]Sokhal AK，Jain NK，Jhanwar A，et al.Prospective study to evaluate the clinical outcome of intralesional interferon-α2b in the management of Peyronie's disease[J]. Urology Annals，2018，10(2)：154-158.
[26]Ziegelmann MJ，Viers BR，Montgomery BD，et al.Self-reported Clinical Meaningfulness Early in the Treatment Course Predicts Objective Outcomes in Men Undergoing Collagenase Clostridium histolyticum Injections for Peyronie Disease[J].Urology，2017(106)：107-112.
, http://www.100md.com
[27]Hellstrom WJG，Tan RBW，Liu G.Safety Profile of Collagenase Clostridium Histolyticum Stratified by Degree of Penile Curvature in Patients With Peyronie Disease[J].Urology，2017， 106(237)：e9-e14.
[28]Abdel Raheem A，Capece M，Kalejaiye O，et al.Safety and effectiveness of collagenase clostridium histolyticum in the treatment of Peyronie's disease using a new modified shortened protocol[J].BJU International，2017，120(5)：717-723.
[29]Carson CC，Sadeghi-Nejad H，Tursi JP，et al.Analysis of the clinical safety of intralesional injection of collagenase Clostridium histolyticum (CCH) for adults with Peyronie's disease(PD)[J].BJU International，2015，116(5)：815-822.
[30]Martínez-Salamanca JI，Egui A，Moncada I，et al.Acute phase Peyronie's disease management with traction device：a nonrandomized prospective controlled trial with ultrasound correlation[J].The Journal of Sexual Medicine，2014，11(2)：506-515., 百拇医药(丁黎)